Seattle Biotech Startup Parse Biosciences Acquires Biomage to Enhance Single-Cell RNA Analysis

Seattle biotech startup Parse Biosciences has acquired Scotland-based Biomage, a single-cell RNA data analysis software company, adding about 10 employees and appointing Biomage's CEO as head of bioinformatics. This follows Parse's $50 million capital raise in December and aims to enhance single-cell sequencing analysis capabilities.